Thymulin reduces the hyperalgesia and cytokine upregulation induced by cutaneous leishmaniasis in mice

Brain, Behavior, and Immunity

Volumn 16, Issue 4, 2002, Pages 450-460

  Kanaan, Salim A ^a   Safieh Garabedian, Bared ^a   Karam, Mark ^a   Khansa, Hala ^b   Jabbur, Suhayl J ^a   Jurjus, Abdo R ^a   Saade, Nayef E ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b LEBANESE UNIVERSITY   (Lebanon)

Author keywords

Cutaneous leishmaniasis; Cytokines; Hyperalgesia; Interleukins; NGF; Thymulin

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; NERVE GROWTH FACTOR; THYMULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HINDLIMB; HOT PLATE TEST; HYPERALGESIA; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SKIN LEISHMANIASIS; SKIN STIMULATION; TAIL FLICK TEST;

EID: 0036431781     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1006/brbi.2001.0631     Document Type: Article

References (34)

1. Bandtlow, C. E., Meyer, M., Lindholm, D., Spranger, M., Heumann, R., & Thoenen, H. (1990). Regional and cellular co-distribution of interleukin 1-β and nerve growth factor mRNA in the adult rat brain: Possible relationship to the regulation of nerve growth factor synthesis. J. Cell Biol. 111, 1701-1711.
2. Bogdan, C., & Röllinghoff, M. (1998). The immune response to Leishmania: Mechanisms of parasite control and evasion. Int. J. Parasitol. 28, 121-134.
3. Dardenne, M., Charreire, J., & Bach, J. F. (1978). Alterations in thymocyte surface markers after in vivo treatment by serum thymic factor. Cell Immunol. 39, 47-54.
4. Dardenne, M., & Savino, W. (1994). Control of thymus physiology by peptidic hormones and neuropeptides. Immunol. Today 15, 518-523.
5. Dardenne, M., Safieh-Garabedian, B., & Pleau, J. M. (2000). Thymic peptides: Transmitters between the neuroendocrine and the immune system. In N. E. Saadé, A. V. Apkarian, & S. J. Jabbur (Eds.), Pain and Neuroimmune Interactions, pp. 127-137. Kluwer Academic/Plenum: New York.
6. Dray, A., & Bevan, S. (1993). Inflammation and hyperalgesia: Highlighting the team effort. Trends Pharmacol. Sci. 14, 287-290.
7. Ferreira, S. H., Lorenzetti, B. B., Btistow, A. F., & Poole, S. (1988). Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334, 698-700.
8. Ferreira, S. H., Lorenzetti, B. B., & Poole, S. (1993). Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br. J. Pharmacol. 110, 1227-1231.
9. Goehler, L. E., Gaykema, R. P., Nguyen, K. T., Lee, J. E., Tilders, F. J. H., Maier, S. F., & Watkins, L. R. (1999). Interleukin-1β in immune cells of the abdominal vagus nerve: A link between the immune and nervous systems? J. Neurosci. 19, 2799-2806.
10. Grevelink, S. A., & Lerner, E. A. (1996). Leishmaniasis. J. Am. Acad. Dermatol. 34, 257-272.
11. Handman, E. F., Symons, M., Baldwin, T. M., Curtis, J. M., & Scheerlinck, J. P. Y. (1995). Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by Th1 type of immune response. Infect. Immun. 63, 4261-4267.
12. Incefy, G. S., Mertelsmann, R., Dardenne, M., Bach, J. F., & Good, R. A. (1980). Induction of differentiation in human marrow T cell precursors by the synthetic serum thymic factor (FTS). Clin. Exp. Immunol. 40, 396-400.
13. Kanaan, S. A., Saadé, N. E., Haddad, J. J., Abdelnoor, A. M., Atweh, S. F., Jabbur, S. J., & Safieh-Garabedian, B. (1996). Endotoxin-induced local inflammation and hyperalgesia in rats and mice: A new model for inflammatory pain. Pain 66, 373-379.
14. Kanaan, S. A., Saadé, N. E., Karam, M., Khansa, H., Jabbur, S. J., & Jurjus, A. R. (2000). Hyperalgesia and upregulation of cytokines and nerve growth factor by cutaneous leishmaniasis in mice. Pain 85, 477-482.
15. Kibbi, A. G., Hassouna, L., & Rubeiz, N. G. (1996). Cutaneous leishmaniasis: An old disease with a new face. Acta Dermatol. Venereol. 76, 171-172.
16. Kubba, R., El-Hassan, A. M., Al-Gindan, Y., Omer, A. H. S., Bushra, M., & Kutty, M. K. (1987). Peripheral nerve involvement in cutaneous leishmaniasis (Old World). Int. J. Dermatol. 26, 527-531.
17. Lewin, G. R., & Mendell, L. M. (1993). Nerve growth factor and nociception. Trends Neurosci. 16, 353-359.
18. Liew, F. Y., & O'Donnell, C. A. (1993). Immunology of leishmaniasis. In J. R. Baker & R. F. Moller (Eds.), Advances of Parasitology, pp. 162-259. Academic Press: New York.
19. Magill, A. J. (1995). Epidemiology of the leishmaniasis. Dermatoepidemiology 13, 505-523.
20. Maier, S. F., Wiertelak, E. P., Martin, D., & Watkins, L. R. (1993). Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res. 623, 321-324.
21. McMahon, S. B., Bennett, D. L. H., & Koltzenburg, M. (1997). The biological effects of nerve growth factor on primary sensory neurons. In D. Borsook (Ed.), Molecular neurobiology of pain, pp. 59-78. IASP Press: Seattle.
22. Poole, S., & Woolf, C. J. (1999). Cytokine-nerve growth factor interactions in inflammatory hyperalgesia. In L. R. Watkins & S. F. Maier (Eds.), Cytokines and pain, pp. 89-132. Birkhauser: Basel.
23. Saadé, N. E., Major, S. C., Jabbur, S. J., Atweh, S. F., Kanaan, S. A., & Safieh-Garabedian, B. (1998). Involvement of capsaicin sensitive primary afferents in thymulin-induced hyperalgesia. J. Neuroimmunol. 91, 171-179.
24. Saadé, N. E., Nasr, I. W., Massaad, C. A., Safieh-Garabedian, B., Jabbur, S. J., & Kanaan, S. A. (2000). Modulation of ultraviolet-induced hyperalgesia and cytokine upregulation by interleukins 10 and 13. Br. J. Pharmacol. 131, 1317-1324.
25. Safieh-Garabedian, B., Kendall, M. D., Khamashta, M. A., & Hughes, G. R. V. (1992). Thymulin and its role in immunomodulation. J. Autoimmun. 5, 547-555.
26. Safieh-Garabedian, B., Ahmed, K., Khamashta, M. A., & Hughes, G. R. V. (1993). Thymulin modulates cytokine release by peripheral blood mononuclear cells: A comparison between healthy volunteers and patients with systemic lupus erythematosus. Int. Arch. Allergy Immunol. 101, 126-131.
27. Safieh-Garabedian, B., Poole, S., Allchorne, A., Winter, J., & Woolf, C. J. (1995). Contribution of interleukin-1β to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br. J. Pharmacol. 115, 1265-1275.
28. Safieh-Garabedian, B., Jalakhian, R. H., Saadé, N. E., Haddad, J. J., Jabbur, S. J., & Kanaan, S. A. (1996). Thymulin reduces hyperalgesia induced by peripheral endotoxin injection in rats and mice. Brain Res. 717, 179-183.
29. 2. J. Neuroimmunol. 73, 162-168.
30. Safieh-Garabedian, B., Jalakhian, R. H., Jabbur, S. J., Saadé, N. E., & Kanaan, S. A. (1998). Thymulin at high doses reduces endotoxin-induced hyperalgesia by reducing interleukin-1β and nerve growth factor levels in the hind paw of rats. In S. N. Ayrapetyan & A. V. Apkarian (Eds.), Pain Mechanisms and Management, pp. 131-138. IOS Press: Amsterdam.
31. Safieh-Garabedian, B., Ochoa-Chaar, C. I., Atweh, S. F., Jabbur, S. J., & Saadé, N. E. (2000). Intracere-broventricular injections of endotoxin induced hyperalgesia and cytokine upregulation which are modulated by thymulin. Soc. Neurosci. Abstr. 26, 1179.
32. Satti, M. B., El-Hassan, A. M., Al-Gindan, Y., Mirghani, A., & Al-Sohaibani, M. O. (1989). Peripheral neural involvement in cutaneous leishmaniasis. Int. J. Dermatol. 28, 243-247.
33. Savino, W., & Dardenne, M. (2000). Neuroendocrine control of thymus physiology. Endocr. Rev. 21(4), 412-443.
34. Zimmerman, M. (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16, 109-110.